Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene

Hidenori Toyoda, Takashi Kumada, Kazuhiko Hayashi, Takashi Honda, Yoshiaki Katano, Hidemi Goto, Takahisa Kawaguchi, Yoshiki Murakami, Fumihiko Matsuda

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Antiviral combination therapy with peginterferon and ribavirin does not induce a therapeutically resistant mutation in the HCV core region regardless of genetic polymorphism near the IL28B gene'. Together they form a unique fingerprint.

Medicine & Life Sciences